CD33 Molecule (CD33) ELISA Kits

Putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. Zusätzlich bieten wir Ihnen CD33 Antikörper (692) und CD33 Proteine (36) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
CD33 945 P20138
CD33 12489 Q63994
CD33 690492  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top CD33 ELISA Kits auf antikoerper-online.de

Showing 10 out of 45 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 31.25 pg/mL 125-8000 pg/mL Typical standard curve 96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$910.56
Details
Maus 0.057 ng/mL 0.15 ng/mL - 10 ng/mL 96 Tests Anmelden zum Anzeigen 13 bis 16 Tage
$682.11
Details
Affe 0.1 ng/mL 0.5-10 ng/mL 96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Kaninchen 0.1 ng/mL 0.5-10 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Meerschweinchen 0.1 ng/mL 0.5-10 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Ratte 0.1 ng/mL 0.5-10 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Schwein 0.094 ng/mL 0.156-10 ng/mL   96 Tests Anmelden zum Anzeigen 12 bis 14 Tage
$715.00
Details
Huhn 0.094 ng/mL 0.156-10 ng/mL   96 Tests Anmelden zum Anzeigen 12 bis 14 Tage
$715.00
Details
Hund 0.1 ng/mL 0.5-10 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Schaf
  96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details

Weitere ELISA Kits für CD33 Interaktionspartner

Human CD33 Molecule (CD33) Interaktionspartner

  1. Identify a subset of cord blood cells with CD33(+)CD34(+)CD38(-)CD45RA(-)CD90(+)CD49f(+) phenotype which are serially transplantable, but have diverse cell output profiles.

  2. Data show that the intensity level of CD33 protein (CD33) on the monocytes is directly related to the rs12459419 single nucleotide polymorphism (SNP) genotypes CC, CT and TT.

  3. These findings demonstrate that C1q and it's globular region interact with CD33 to activate its inhibitory motifs, while the collagen-like region does not. Whole C1q is required to crosslink CD33 and LAIR-1 and concurrently activate CD33/LAIR-1 inhibitory motifs.

  4. rs3865444 CD33 acts as a protective factor against late-onset Alzheimer's disease.

  5. Genetic variations in CD33 influence atrophy of specific Alzheimer's Disease-related brain structures; specifically the hippocampus and parahippocampal gyrus.

  6. The mean percentage of CD33-positivity of the myeloblast population was 80.5% in acute myeloid leukemia (AML), 81.8% in chronic myelomonocytic leukemia (CMML) and 75% in myelodysplastic syndromes (MDS).

  7. The 161533 TriKE induced superior NK cell cytotoxicity, degranulation, and cytokine production against CD33(+) HL-60 targets and increased NK survival and proliferation.

  8. High efficacy of CD33/CD3 TandAbs in various preclinical models of human AML.

  9. The use of CD33(+)CD11b(+)HLA-DR(-) cells as a predictive and prognostic biomarker.

  10. Data suggest that two SNPs in CD33 (rs3865444A, rs12459419T) that are protective of Alzheimer disease result in splice variants (CD33M, CD33m); CD33M localizes predominantly at cell surface in macrophage cell line; CD33m is primary intracellular form in neutrophils and a microglia cell line; intracellular CD33m accumulates in peroxisomes; activation of macrophages/neutrophils does not mobilize CD33m to cell surface.

  11. In cutaneous diffuse large b-cell lymphoma, a considerable proportion of CD33(+) myeloid-derived suppressor cells (MDSCs) with PD-L1 coexpression was admixed. Tumor cells expressed CD33 to variable degrees (2% to 60%). We propose that PD-L1(+) tumor cells and PD-L1(+) MDSCs shield the tumor against PD-1(+) tumor-infiltrating lymphocytes, consequently leading to inhibition and diminution of tumor-infiltrating lymphocytes.

  12. patients with the CC genotype for rs12459419 have a substantial response to Gemtuzumab Ozogamicin, making this a potential biomarker for the selection of patients with a likelihood of significant response to Gemtuzumab Ozogamicin.

  13. CD33-expressing microglia play a central role in the development of leukoencephalopathy in Nasu-Hakola disease brains

  14. There is substantial evidence that rs3865444 (CD33) function is related to AD pathways and pathology, but our data does not support an interaction with rs670139 (MS4A4E) that impacts AD risk.

  15. this study investigated the contribution of the immunoregulatory receptor CD33 to a uniquely human postreproductive disease, Alzheimer's dementia.

  16. the CD33 rs3865444 polymorphism is associated with Alzheimer's disease susceptibility in Chinese, European, and North American populations.

  17. CD33 and MS4A cluster variants are associated with LOAD susceptibility in East Asian populations.

  18. Among those with one or more APOE epsilon4 alleles, having one or more copies of the CD33 C (risk) allele may further increase the risk of cognitive decline

  19. decreased TREM2 expression with CD33 suppression and elevated cortical TREM2 mRNA expression with amyloid pathology

  20. we propose a model wherein a modest effect on RNA splicing is sufficient to mediate the CD33 association with AD risk and suggest the potential for an anti-CD33 antibody as an AD-relevant pharmacologic agent.

Mouse (Murine) CD33 Molecule (CD33) Interaktionspartner

  1. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.

  2. CD33-related Siglec-E recognizes the intact neuron and has neuroprotective function by preventing phagocytosis.

  3. mCD33 is expressed on myeloid precursors in the bone marrow

  4. SOCS3 inhibited the CD33-induced block on cytokine-induced proliferation. SOCS3 and its target protein CD33 are degraded concomitantly concomitantly.

CD33 Antigen-Profil

Beschreibung des Gens

Putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Induces apoptosis in acute myeloid leukemia (in vitro).

Genbezeichner und Symbole assoziert mit CD33 Molecule (CD33) ELISA Kits

  • CD33 molecule (CD33) Antikörper
  • CD33 antigen (Cd33) Antikörper
  • CD33 molecule (Cd33) Antikörper
  • gp67 Antikörper
  • p67 Antikörper
  • Siglec-3 Antikörper
  • SIGLEC3 Antikörper

Bezeichner auf Proteinebene für CD33 Molecule (CD33) ELISA Kits

CD33 antigen (gp67) , gp67 , myeloid cell surface antigen CD33 , sialic acid binding Ig-like lectin 3 , sialic acid-binding Ig-like lectin 3

GENE ID SPEZIES
945 Homo sapiens
456242 Pan troglodytes
12489 Mus musculus
690492 Rattus norvegicus
102117580 Macaca fascicularis
719855 Macaca mulatta
Ausgewählte Anbieter für CD33 (CD33) ELISA Kits
Haben Sie etwas anderes gesucht?